JP2016501844A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016501844A5 JP2016501844A5 JP2015540743A JP2015540743A JP2016501844A5 JP 2016501844 A5 JP2016501844 A5 JP 2016501844A5 JP 2015540743 A JP2015540743 A JP 2015540743A JP 2015540743 A JP2015540743 A JP 2015540743A JP 2016501844 A5 JP2016501844 A5 JP 2016501844A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- compound according
- acceptable salt
- compound
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000001875 compounds Chemical class 0.000 claims 9
- 150000003839 salts Chemical class 0.000 claims 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 208000006575 hypertriglyceridemia Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 0 C[C@](*1)(SC)[U]CCCc2c1cc(*)cc2 Chemical compound C[C@](*1)(SC)[U]CCCc2c1cc(*)cc2 0.000 description 5
- MEFBFOAEVCSUND-UHFFFAOYSA-N C[I](C)[N-](CCc1ccccc11)C1=O Chemical compound C[I](C)[N-](CCc1ccccc11)C1=O MEFBFOAEVCSUND-UHFFFAOYSA-N 0.000 description 1
- NUBQPEPTQRWIPT-UHFFFAOYSA-N O=C1OC2C=CC=CC2NC1 Chemical compound O=C1OC2C=CC=CC2NC1 NUBQPEPTQRWIPT-UHFFFAOYSA-N 0.000 description 1
Claims (9)
- 下式の化合物:
Lは、−CH2−および−CH2CH2−から選択され、
R1は、−CH3および−CF3から選択され、
Aは、
(式中、
Tは、CH2、NHおよびOから選択され、
Uは、CH2、NHおよびOから選択され、
Vは、CH2、C=O、NH、N−CH3およびOから選択され、
但しT、UおよびVの少なくとも1つはCH2であるが全部ではなく、かつUがOである場合はTおよびVのそれぞれはOまたはN以外であり、
Wは、CH2およびOから選択され、
Xは、CHおよびNから選択され、但しWがCH2の場合、XはNであり、WがOの場合、XはCHであり、
Yは、CH2、N−C6H5およびOから選択され、
Zは、CH2およびOから選択され、
R2は、Hおよびハロゲンから選択され、
R3は、H、シクロプロピルおよびフェニルから選択され、
R4は、Hおよびフェニルから選択され、
およびその薬学的に許容可能な塩。 - Lは-CH2−である、請求項1または2に記載の化合物。
- R1は-CH3である、請求項1から3のいずれか一項に記載の化合物。
- R1は-CF3である、請求項1から3のいずれか一項に記載の化合物。
- 請求項1から7のいずれか一項に記載の化合物またはその薬学的に許容可能な塩および薬学的に許容可能な担体、希釈剤もしくは賦形剤のうちの少なくとも1種を含む、医薬組成物。
- 高トリグリセリド血症を治療する薬品の製造における、請求項1から7のいずれか一項に記載の化合物またはその薬学的に許容可能な塩の使用。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12382431 | 2012-11-06 | ||
EP12382431.0 | 2012-11-06 | ||
US201361748935P | 2013-01-04 | 2013-01-04 | |
US61/748,935 | 2013-01-04 | ||
PCT/US2013/067466 WO2014074365A1 (en) | 2012-11-06 | 2013-10-30 | Novel benzyl sulfonamide compounds useful as mogat-2 inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2016501844A JP2016501844A (ja) | 2016-01-21 |
JP2016501844A5 true JP2016501844A5 (ja) | 2016-11-24 |
Family
ID=47143796
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015540743A Ceased JP2016501844A (ja) | 2012-11-06 | 2013-10-30 | MoGAT−2阻害剤として有用な新規のベンジルスルホンアミド化合物 |
Country Status (11)
Country | Link |
---|---|
US (1) | US9416138B2 (ja) |
EP (1) | EP2917194B1 (ja) |
JP (1) | JP2016501844A (ja) |
KR (1) | KR20150063519A (ja) |
CN (1) | CN104768941B (ja) |
AU (1) | AU2013341584A1 (ja) |
BR (1) | BR112015009567A2 (ja) |
CA (1) | CA2886831A1 (ja) |
EA (1) | EA201590696A1 (ja) |
MX (1) | MX2015005739A (ja) |
WO (1) | WO2014074365A1 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013112323A1 (en) | 2012-01-23 | 2013-08-01 | Eli Lilly And Company | Phenyl methanesulfonamide derivatives useful as mgat - 2 inhibitors |
WO2013116065A1 (en) | 2012-01-31 | 2013-08-08 | Eli Lilly And Company | Novel morpholinyl derivatives useful as mogat-2 inhibitors |
EP3395798A4 (en) | 2015-12-21 | 2019-07-17 | Shionogi & Co., Ltd | NON-AROMATIC HETEROCYCLIC DERIVATIVE HAVING MGAT2 INHIBITORY ACTIVITY |
TWI782056B (zh) | 2017-07-14 | 2022-11-01 | 日商鹽野義製藥股份有限公司 | 具有mgat2抑制活性的縮合環衍生物 |
BR112021012428A2 (pt) | 2019-01-11 | 2021-09-08 | Shionogi & Co., Ltd. | Derivado de dihidropirazolopirazinona tendo atividade inibitória de mgat2 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0784612A1 (en) * | 1994-10-04 | 1997-07-23 | Fujisawa Pharmaceutical Co., Ltd. | Urea derivatives and their use as acat-inhibitors |
GB9702194D0 (en) | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
EA012260B1 (ru) * | 2002-01-29 | 2009-08-28 | Лаборатуар Сероно Са | ЗАМЕЩЁННЫЕ ПРОИЗВОДНЫЕ МЕТИЛЕНАМИДА В КАЧЕСТВЕ МОДУЛЯТОРОВ ПРОТЕИНТИРОЗИНФОСФАТАЗ (PTPs) |
US7820704B2 (en) * | 2004-04-20 | 2010-10-26 | Transtech Pharma, Inc. | Substituted heteroaryl derivatives, compositions, and methods of use |
EP1659113A1 (en) * | 2004-11-08 | 2006-05-24 | Evotec AG | Inhibitors of 11beta-hydroxy steroid dehydrogenase type 1 (11beta-HSD1) |
EP1655283A1 (en) * | 2004-11-08 | 2006-05-10 | Evotec OAI AG | 11beta-HSD1 Inhibitors |
JPWO2008038768A1 (ja) * | 2006-09-28 | 2010-01-28 | 大日本住友製薬株式会社 | 二環性ピリミジン構造を有する化合物及びそれを含有する医薬組成物 |
TW200831092A (en) * | 2006-12-21 | 2008-08-01 | Astrazeneca Ab | Therapeutic agents |
US20110275647A1 (en) | 2009-02-23 | 2011-11-10 | Msd K.K. | Pyrimidin-4-(3h)-one derivatives |
MX2011011082A (es) * | 2009-04-20 | 2011-11-04 | Abbott Lab | Derivados de amida y amidina novedosos y usos de los mismos. |
US8507493B2 (en) * | 2009-04-20 | 2013-08-13 | Abbvie Inc. | Amide and amidine derivatives and uses thereof |
WO2013112323A1 (en) | 2012-01-23 | 2013-08-01 | Eli Lilly And Company | Phenyl methanesulfonamide derivatives useful as mgat - 2 inhibitors |
AR089771A1 (es) | 2012-01-31 | 2014-09-17 | Lilly Co Eli | Derivados de bencil sulfonamida utiles como inhibidores de mogat-2 |
WO2013116065A1 (en) | 2012-01-31 | 2013-08-08 | Eli Lilly And Company | Novel morpholinyl derivatives useful as mogat-2 inhibitors |
-
2013
- 2013-10-30 EP EP13789443.2A patent/EP2917194B1/en active Active
- 2013-10-30 BR BR112015009567A patent/BR112015009567A2/pt not_active IP Right Cessation
- 2013-10-30 WO PCT/US2013/067466 patent/WO2014074365A1/en active Application Filing
- 2013-10-30 JP JP2015540743A patent/JP2016501844A/ja not_active Ceased
- 2013-10-30 US US14/438,435 patent/US9416138B2/en not_active Expired - Fee Related
- 2013-10-30 CN CN201380057789.8A patent/CN104768941B/zh not_active Expired - Fee Related
- 2013-10-30 MX MX2015005739A patent/MX2015005739A/es unknown
- 2013-10-30 KR KR1020157011222A patent/KR20150063519A/ko not_active Application Discontinuation
- 2013-10-30 EA EA201590696A patent/EA201590696A1/ru unknown
- 2013-10-30 CA CA2886831A patent/CA2886831A1/en not_active Abandoned
- 2013-10-30 AU AU2013341584A patent/AU2013341584A1/en not_active Abandoned